Noradrenergic Cell Specific Gene Transfer With Neuronal Nitric Oxide Synthase Reduces Cardiac Sympathetic Neurotransmission in Hypertensive Rats
- 1 July 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 50 (1), 69-74
- https://doi.org/10.1161/hypertensionaha.107.088591
Abstract
Nitric oxide–cGMP pathway can inhibit cardiac norepinephrine (NE) release. Sympathetic hyper-responsiveness in hypertension may result from oxidative stress impairing this pathway. We tested the hypothesis that the gene transfer of neuronal NO synthase (nNOS) could restore sympathetic balance in the spontaneously hypertensive rat (SHR). An adenovirus (5×10 10 particles) constructed with a noradrenergic neuron-specific promoter (PRS ×8) encoding nNOS (Ad.PRS-nNOS) or enhanced green fluorescence protein (Ad.PRS-eGFP) was targeted to the right atrial wall by percutaneous injection in age-matched male SHRs and Wistar-Kyoto (WKY) rats. Five days after transduction, right atria were removed, and evoked [ 3 H] norephinephrine (NE) release, NOS activity, and cGMP were measured. In the Ad.PRS-eGFP treated group, tissue levels of cGMP were significantly lower in the SHR compared with the WKY atria. NE release was also greater in the SHR, and soluble guanylate cyclase inhibition did not alter evoked [ 3 H] NE release in the Ad.PRS-eGFP–treated SHR. All atria treated with Ad.PRS-nNOS had enhanced nNOS activity when compared with Ad.PRS-eGFP atria. Ad.PRS-nNOS in WKY rats reduced NE release compared with the Ad.PRS-eGFP group. Guanylate cyclase inhibition enhanced NE release in both Ad.PRS-nNOS– and Ad.PRS-eGFP–treated WKY atria. Ad.PRS-nNOS restored cGMP levels in the SHR to those seen in the WKY atria. In the SHR, Ad.PRS-nNOS also attenuated NE release compared with Ad.PRS-eGFP group. This was reversed by guanylate cyclase inhibition. We conclude that artificial upregulation of sympathetic nNOS via gene transfer with a noradrenergic promoter may provide a novel approach for correcting peripheral sympathetic hyperactivity in hypertension.Keywords
This publication has 33 references indexed in Scilit:
- Novel Mechanisms of Sympathetic Regulation in Chronic Heart FailureHypertension, 2006
- Remodeling of the Cardiac Pacemaker L-Type Calcium Current and Its β-Adrenergic Responsiveness in Hypertension After Neuronal NO Synthase Gene TransferHypertension, 2006
- Increased Sympathetic Nerve Activity Correlates With Neurovascular Compression at the Rostral Ventrolateral MedullaHypertension, 2006
- Sympathetic Activity and Cardiovascular Risk Factors in Young Men in the Low, Normal, and High Blood Pressure RangesHypertension, 2006
- Sympatho-Inhibitory Action of Endogenous Adrenomedullin Through Inhibition of Oxidative Stress in the BrainHypertension, 2005
- Cardiac nitric oxide: Emerging role for nNOS in regulating physiological functionPharmacology & Therapeutics, 2005
- Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by HypertensionHypertension, 2004
- Nitric oxide and hypertension: not just an endothelium derived relaxing factor!Journal of Human Hypertension, 2001
- Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionThe American Journal of Cardiology, 1987
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984